Philip Lazarovici

About Philip Lazarovici

Philip Lazarovici, With an exceptional h-index of 57 and a recent h-index of 26 (since 2020), a distinguished researcher at Hebrew University of Jerusalem, specializes in the field of Pharmacology- Neuroscience.

His recent articles reflect a diverse array of research interests and contributions to the field:

Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor …

Artemisinin Confers Cytoprotection toward Hydrogen Peroxide-Induced Cell Apoptosis in Retinal Pigment Epithelial Cells in Correlation with the Increased Acetylation of Histone …

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases

Gabapentin increases intra-epidermal and peptidergic nerve fibers density and alleviates allodynia and thermal hyperalgesia in a mouse model of acute taxol-induced peripheral …

Pharmacological therapies and drug development targeting SARS-CoV-2 infection

Ring-Opening Polymerization (ROP) of Phenylalanine Derived O-Carboxyanhydride (OCA) Using Different Mono-and Bimolecular Conjugated Catalysts and Amino or Alcohol Initiators

Soy-Derived Bioactive Peptides for Use in Compositions and Methods for Wound Healing, Tissue Engineering, and Regenerative Medicine

Current progress on neuroprotection induced by Artemisia, Ginseng, Astragalus, and Ginkgo traditional Chinese medicines for the therapy of Alzheimer’s disease

Philip Lazarovici Information

University

Position

Professor of Pharmacology The

Citations(all)

11617

Citations(since 2020)

2733

Cited By

9983

hIndex(all)

57

hIndex(since 2020)

26

i10Index(all)

180

i10Index(since 2020)

75

Email

University Profile Page

Google Scholar

Philip Lazarovici Skills & Research Interests

Pharmacology- Neuroscience

Top articles of Philip Lazarovici

Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor …

Pharmaceuticals

2024/4/24

Hanoch Senderowitz
Hanoch Senderowitz

H-Index: 16

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Artemisinin Confers Cytoprotection toward Hydrogen Peroxide-Induced Cell Apoptosis in Retinal Pigment Epithelial Cells in Correlation with the Increased Acetylation of Histone …

Molecules

2024/4/15

Chao Yang
Chao Yang

H-Index: 9

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases

2024/1/16

Chao Yang
Chao Yang

H-Index: 9

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Gabapentin increases intra-epidermal and peptidergic nerve fibers density and alleviates allodynia and thermal hyperalgesia in a mouse model of acute taxol-induced peripheral …

Biomedicines

2022/12/8

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Pharmacological therapies and drug development targeting SARS-CoV-2 infection

2022/12/1

Ring-Opening Polymerization (ROP) of Phenylalanine Derived O-Carboxyanhydride (OCA) Using Different Mono-and Bimolecular Conjugated Catalysts and Amino or Alcohol Initiators

ACS Applied Polymer Materials

2022/9/15

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Soy-Derived Bioactive Peptides for Use in Compositions and Methods for Wound Healing, Tissue Engineering, and Regenerative Medicine

2022/7/7

Current progress on neuroprotection induced by Artemisia, Ginseng, Astragalus, and Ginkgo traditional Chinese medicines for the therapy of Alzheimer’s disease

2022/6/14

Stem Cells Aging

2022/5/24

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Research progress on neuroprotection of insulin-like growth factor-1 towards glutamate-induced neurotoxicity

2022/2/14

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

2022

Synthesis and pharmacological characterization of Visabron, a backbone cyclic peptide dual antagonist of α4β1 (VLA-4)/α9β1 integrin for therapy of multiple sclerosis

Pharmacology Research & Perspectives

2019/10

Neurotrophic factors and their receptors in lung development and implications in lung diseases

2021/6/1

Peter I Lelkes
Peter I Lelkes

H-Index: 30

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Novel humanin analogs confer neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell death insults

Peptides

2020/12/1

Mahmoud Taha
Mahmoud Taha

H-Index: 2

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Cyclizing painkillers: development of backbone-cyclic TAPS analogs

Frontiers in Chemistry

2020/11/12

Methylene-cycloalkylacetate derivatives and their use in treatment of neurotropic conditions

2020/7/30

Integrin α2β1-Targeted Self-Assembled Nanocarriers for Tumor Bioimaging

ACS Applied Bio Materials

2020/7/27

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Ofra Benny
Ofra Benny

H-Index: 18

Neurotropic activity and safety of methylene-cycloalkylacetate (MCA) derivative 3-(3-allyl-2-methylenecyclohexyl) propanoic acid

ACS Chemical Neuroscience

2020/7/15

Philip Lazarovici
Philip Lazarovici

H-Index: 25

Pristimerin‐induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway

Journal of Cellular and Molecular Medicine

2020/6

Shuai Li
Shuai Li

H-Index: 15

Yizhou Jiang
Yizhou Jiang

H-Index: 16

Philip Lazarovici
Philip Lazarovici

H-Index: 25

FoxO3a suppresses neuropeptide W expression in neuronal cells and in rat hypothalamus and its implication in hypothalamic-pituitary-adrenal (HPA) axis

International Journal of Biological Sciences

2020

See List of Professors in Philip Lazarovici University(Hebrew University of Jerusalem)